Medmira Inc. Stock
€0.049
Your prediction
Pros and Cons of Medmira Inc. in the next few years
Pros
Cons
Performance of Medmira Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Medmira Inc. | - | -2.970% | 1.031% | -17.647% | -24.615% | - | - |
Theralase Technologies Inc | 3.570% | -0.855% | 7.407% | -32.164% | 11.538% | -23.179% | -59.384% |
InVivo Therapeutics Holdings | -15.070% | -26.190% | -27.059% | -79.672% | -63.953% | -99.948% | -99.948% |
Atossa Genetics Inc | 3.580% | -9.319% | -16.086% | -8.911% | 7.545% | -78.468% | -72.970% |
News
MedMira Announces the Hire of Vice President of Business Development
Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the
MedMira gibt Einstellung eines Vizepräsidenten für Geschäftsentwicklung bekannt
Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
Halifax, Nova Scotia, March 13, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent (number 2,949,634) for its new innovative and quantitative test